{
    "clinical_study": {
        "@rank": "70510", 
        "acronym": "iSPOT", 
        "arm_group": [
            {
                "arm_group_label": "MultiSpot pacing", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "MultiVein pacing", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Standard biventricular pacing", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the iSPOT Study is to evaluate the contractility using positive left\n      ventricular (LV) dP/dt max across LV pacing site(s) in patients indicated for cardiac\n      resynchronization therapy (CRT)."
        }, 
        "brief_title": "Left Ventricular MultiSpot Pacing for CRT (iSPOT)", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is indicated for CRT or CRT-D device according to current applicable ESC/AHA\n             guidelines\n\n          -  Subject has a left bundle branch block (LBBB) conduction pattern\n\n          -  Subject is in stable sinus rhythm at the time of implant (no atrial arrhythmias\n             lasting > 30 seconds during the last 2 weeks prior to inclusion and no documented\n             AF-episodes allowed during the last 2 weeks prior to inclusion)\n\n          -  Subject receives optimal heart failure oral medical therapy (ACE inhibitor and/or ARB\n             and Beta Blockers), and is on a stable medication scheme for at least 1 month prior\n             to enrollment\n\n          -  Subject (or the legal guardian) is willing to sign informed consent form\n\n          -  Subject is 18 years or older or as specified  minimal age per local law/regulation\n\n        Exclusion Criteria:\n\n          -  Subject has permanent atrial fibrillation/ flutter or tachycardia\n\n          -  Subject experienced recent myocardial infarction (MI), within 40 days prior to\n             enrollment\n\n          -  Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90\n             days prior to enrollment\n\n          -  Subject is post heart transplantation, or is actively listed on the transplantation\n             list\n\n          -  Subject is implanted with a left ventricular assist device (LVAD)\n\n          -  Subject is on chronic renal dialysis\n\n          -  Subject has severe renal disease (defined as estimated Glomerular Filtration Rate\n             (equation provided by Modification of Diet in Renal Disease study): (eGFR) < 30\n             mL/min/1.73m2)\n\n          -  Subject is on continuous or uninterrupted infusion (inotropic) therapy for heart\n             failure (\u2265 2 stable infusions per week)\n\n          -  Subject has severe aortic stenosis (with a valve area of <1.0 cm2 or significant\n             valve disease expected to be operated within study period)\n\n          -  Subject has complex and uncorrected congenital heart disease\n\n          -  Subject has a mechanical heart valve\n\n          -  Pregnant or breastfeeding women, or women of child bearing potential and who are not\n             on a reliable form of birth control\n\n          -  Subject is enrolled in one or more concurrent studies that would confound the results\n             of this study\n\n          -  Subject is already implanted with a device"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01883141", 
            "org_study_id": "iSPOT"
        }, 
        "intervention": [
            {
                "arm_group_label": "MultiSpot pacing", 
                "description": "Subjects will receive pacing from one right ventriclar lead and one left ventricular catheter/lead with multiple LV pacing spots", 
                "intervention_name": "MultiSpot pacing", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "MultiVein pacing", 
                "description": "Subjects will receive pacing from one right ventriclar lead and two left ventricular catheter/lead(s)", 
                "intervention_name": "MultiVein pacing", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Standard biventricular pacing", 
                "description": "Subjects will receive standard biventricular pacing from one right ventriclar lead and one left ventricular catheter/lead", 
                "intervention_name": "Standard biventricular pacing", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Marc Vanderheyden, Dr"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium", 
                        "zip": "9300"
                    }, 
                    "name": "Onze-Lieve-Vrouwziekenhuis Aalst"
                }, 
                "investigator": {
                    "last_name": "Marc Vanderheyden, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Frederic van Heuverswyn, Dr"
                }, 
                "facility": {
                    "address": {
                        "city": "Gent", 
                        "country": "Belgium", 
                        "zip": "B-9000"
                    }, 
                    "name": "Universitair Ziekenhuis Gent"
                }, 
                "investigator": {
                    "last_name": "Frederic Van Heuverswyn, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ashkelon", 
                        "country": "Israel", 
                        "zip": "78278"
                    }, 
                    "name": "Barzilai Medical Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maciej Sterli\u0144ski"
                }, 
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland", 
                        "zip": "02-637"
                    }, 
                    "name": "Klinika Choroby Wie\u0144cowej"
                }, 
                "investigator": {
                    "last_name": "Maciej Sterli\u0144ski", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrzej Przybylski"
                }, 
                "facility": {
                    "address": {
                        "city": "Warsaw", 
                        "country": "Poland", 
                        "zip": "04-628"
                    }, 
                    "name": "Klinika Zaburze\u0144 Rytmu Serca"
                }, 
                "investigator": {
                    "last_name": "Andrzej Przybylski", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Zbigniew Kalarus, Prof. Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Zabrze", 
                        "country": "Poland", 
                        "zip": "44-800"
                    }, 
                    "name": "Medical University of Silesia"
                }, 
                "investigator": {
                    "last_name": "Zbigniew Kalarus, Prof. Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Aldo Rinaldi, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "SE 1 7EH"
                    }, 
                    "name": "Guys and St. Thomas NHS Trust"
                }, 
                "investigator": {
                    "last_name": "Christopher Aldo Rinaldi, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "W2 I NY"
                    }, 
                    "name": "Imperial College Healthcare NHS Trust"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Israel", 
                "Poland", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "Left Ventricular MultiSpot Pacing for CRT (iSPOT)", 
        "overall_contact": {
            "email": "joeri.heynens@medtronic.com", 
            "last_name": "Joeri Heynens, Msc, Ir.", 
            "phone": "+31(0)43 3566634"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicinal Products and Health Products", 
                "Israel: Ministry of Health", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measure the change in positive left ventricular (LV) dP/dt max (mm HG/sec) of multispot LV pacing configuration compared to normal biventricular pacing in patients undergoing a research study, an electrophysiological exploratory procedure or CRT-implant", 
            "measure": "Change in positive left ventricular (LV) dP/dt max (mm HG/sec) of multispot LV pacing configuration compared to normal biventricular pacing", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed for the time of the EP procedure, which has an average duration of 2 to 3 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01883141"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measure the change in positive left ventricular (LV) dP/dt max (mm HG/sec) of multi-vein LV pacing configuration compared to normal biventricular pacing in patients undergoing a research study, an electrophysiological exploratory procedure or CRT-implant", 
                "measure": "Change in positive left ventricular (LV) dP/dt max (mm HG/sec) of multi-vein LV pacing configuration compared to normal biventricular pacing", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the time of the EP procedure, which has an average duration of 2 to 3 hours"
            }, 
            {
                "description": "Measure the change in positive left ventricular (LV) dP/dt max (mm HG/sec) of multi-vein LV pacing configuration compared to multispot LV pacingin patients undergoing a research study, an electrophysiological exploratory procedure or CRT-implant", 
                "measure": "Change in positive left ventricular (LV) dP/dt max (mm HG/sec) of multi-vein LV pacing configuration compared to multispot LV pacing configuration", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the time of the EP procedure, which has an average duration of 2 to 3 hours"
            }, 
            {
                "description": "Correlate blood pressure, EGMs and electrocardiographic mapping measurements with the positive LV dP/dt max values obtained during each of the three pacing configuration's (BiV, MultiVein and MultiSpot)", 
                "measure": "Correlation of blood pressure, EGMs and electrocardiographic mapping measurements with the positive LV dP/dt max values", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the time of the EP procedure, which has an average duration of 2 to 3 hours"
            }, 
            {
                "description": "Evaluate whether the non-invasive measurements that are also collected during the study can identify the pacing configuration with the highest positive LV dP/dt max", 
                "measure": "Use of non-invasive measurements to identify pacing configuration with highest positive LV dP/dt max", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the time of the EP procedure, which has an average duration of 2 to 3 hours"
            }, 
            {
                "description": "Evaluate the within patient variability in positive LV dP/dt max measurements", 
                "measure": "Within patient variability in positive LV dP/dt max", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the time of the EP procedure, which has an average duration of 2 to 3 hours"
            }
        ], 
        "source": "Medtronic Bakken Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Bakken Research Center", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}